Prognostic significance of absolute lymphocyte count at diagnosis of diffuse large B-cell lymphoma: A meta-analysis

International Journal of Hematology

Volumn 95, Issue 2, 2012, Pages 143-148

  Feng, Jianhua ^a   Wang, Zhujun ^a   Guo, Xiaoping ^a   Chen, Yuanyuan ^a   Cheng, Yuping ^a   Tang, Yongmin ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Absolute lymphocyte count; Diffuse large b cell lymphoma; Meta analysis; Prognosis; Survival

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; LACTATE DEHYDROGENASE; RITUXIMAB;

CANCER PROGNOSIS; CANCER SURVIVAL; HUMAN; LARGE CELL LYMPHOMA; LYMPHOCYTE COUNT; META ANALYSIS; OVERALL SURVIVAL; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; PUBLICATION; REVIEW; SYSTEMATIC REVIEW; METHODOLOGY; MORTALITY; PROGNOSIS; RISK FACTOR;

HUMANS; LYMPHOCYTE COUNT; LYMPHOMA, LARGE B-CELL, DIFFUSE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 84862639040     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0993-6     Document Type: Review

References (32)

1. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-49.
2. Coiffier B. State-of-the-art therapeutics: diffuse large B-cell lymphoma. J Clin Oncol. 2005;23:6387-93. (Pubitemid 46218851)
3. Hawkins CA, Collignon P, Adams DN, Bowden FJ, Cook MC. Profound lymphopenia and bacteraemia. Intern Med J. 2006;36: 385-8. (Pubitemid 43780701)
4. Heimann TM, Bolnick K, Aufses A H Jr. Prognostic significance of severe preoperative lymphopenia in patients with Crohn's disease. Ann Surg. 1986;203:132-5. (Pubitemid 16144698)
5. Rudiger A, Burckhardt OA, Harpes P, Muller SA, Follath F. The relative lymphocyte count on hospital admission is a risk factor for long-term mortality in patients with acute heart failure. Am J Emerg Med. 2006;24:451-4. (Pubitemid 43922449)
6. Porrata LF, Ristow KM, Markovic SN, Persky D, Habermann TM. Lymphocyte count persistence and early recovery predicts superior survival and is independent of the international prognostic index in patients treated with CHOP chemotherapy for diffuse large B cell lymphoma. Blood. 2004;104:3252.
7. Porrata LF, Ristow KM, Geyer SM, Markovic SN, Persky DO, Colgan JP, et al. Absolute lymphocyte count recovery predicts superior survival and is independent of the international prognostic index in patients treated with CHOP or R-CHOP chemotherapy for diffuse large B cell lymphoma. Blood. 2005;106:931.
8. Siddiqui M, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP, et al. Absolute lymphocyte count predicts overall survival in follicular lymphomas. Br J Haematol. 2006;134: 596-601. (Pubitemid 44253601)
9. Behl D, Ristow K, Markovic SN, Witzig TE, Habermann TM, Colgan JP, et al. Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomas. Br J Haematol. 2007;137:409-15. (Pubitemid 46698290)
10. Kim DH, Baek JH, Chae YS, Kim YK, Kim HJ, Park YH, et al. Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma. Leukemia. 2007;21:2227-30. (Pubitemid 47423827)
11. Plonquet A, Haioun C, Jais JP, Debard AL, Salles G, Bene MC, et al. Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma. Ann Oncol. 2007;18:1209-15. (Pubitemid 47244368)
12. Bari A, Marcheselli L, Sacchi S, Marcheselli R, Pozzi S, Ferri P, et al. Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story. Ann Oncol. 2010;21: 1486-91.
13. Porrata LF, Inwards DJ, Ansell SM, Micallef IN, Johnston PB, Hogan WJ, et al. New-onset lymphopenia assessed during routine follow-up is a risk factor for relapse postautologous peripheral blood hematopoietic stem cell transplantation in patients with diffuse large B-cell lymphoma. Biol Blood Marrow Transplant. 2010;16:376-83.
14. Porrata LF, Ristow K, Habermann TM, Witzig TE, Inwards DJ, Markovic SN. Absolute lymphocyte count at the time of first relapse predicts survival in patients with diffuse large B-cell lymphoma. Am J Hematol. 2009;84:93-7.
15. Cox MC, Nofroni I, Laverde G, Ferrari A, Amodeo R, Tatarelli C, et al. Absolute lymphocyte count is a prognostic factor in diffuse large B-cell lymphoma. Br J Haematol. 2008;141:265-8. (Pubitemid 351406210)
16. Talaulikar D, Choudhury A, Shadbolt B, Brown M. Lymphocytopenia as a prognostic marker for diffuse large B cell lymphomas. Leuk Lymphoma. 2008;49:959-64. (Pubitemid 351942751)
17. Oki Y, Yamamoto K, Kato H, Kuwatsuka Y, Taji H, Kagami Y, et al. Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab. Eur J Haematol. 2008; 81:448-53.
18. Cox MC, Nofroni I, Ruco L, Amodeo R, Ferrari A, La Verde G, et al. Low absolute lymphocyte count is a poor prognostic factor in diffuse-large-B-cell- lymphoma. Leuk Lymphoma. 2008;49: 1745-51.
19. Song MK, Chung JS, Seol YM, Kim SG, Shin HJ, Choi YJ, et al. Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy. Ann Oncol. 2010;21:140-4.
20. Wilcox RA, Ristow K, Habermann TM, Inwards DJ, Micallef IN, Johnston PB, et al. The absolute monocyte and lymphocyte prognostic score predicts survival and identifies high-risk patients in diffuse large-B-cell lymphoma. Leukemia. 2011;25:1502-9.
21. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-34. (Pubitemid 28562978)
22. Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Meta-analysis of randomized clinical trials comparing Cisplatin to Carboplatin in patients with advanced non-small-cell lung cancer. J Clin Oncol. 2004;22:3852-9. (Pubitemid 41079865)
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-88. (Pubitemid 17189972)
24. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50: 1088-101.
25. Egger M, Davey SG, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315: 629-34. (Pubitemid 27387172)
26. Franklin J, Paulus U, Lieberz D, Breuer K, Tesch H, Diehl V. Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? German Hodgkin Lymphoma Study Group. Ann Oncol. 2000;11:617-23. (Pubitemid 30431388)
27. Porrata LF, Ristow K, Witzig TE, Tuinistra N, Habermann TM, Inwards DJ, et al. Absolute lymphocyte count predicts therapeutic efficacy and survival at the time of radioimmunotherapy in patients with relapsed follicular lymphomas. Leukemia. 2007;21: 2554-6. (Pubitemid 350148906)
28. Prochazka V, Trneny M, Salek D, Kozak T, Papajik T, Pytlik R, et al. Median absolute lymphocyte count independently predicts survival of elderly patients with diffuse large B-cell lymphoma treated with R-chemotherapy: analysis of 651 patients included In the Czech lymphoma project. Blood. 2010;116:1187-8.
29. Anderson TC, Jones SE, Soehnlen BJ, Moon TE, Griffith K, Stanley P. Immunocompetence and malignant lymphoma: immunologic status before therapy. Cancer. 1981;48:2702-9. (Pubitemid 12194263)
30. Shohat B, Joshua H, Ben-Bassat M. Investigation of the cellular immunocompetence in chronic lymphatic leukemia and malignant lymphoma patients as assessed by the local graft versus host reaction in rats. J Reticuloendothel Soc. 1974;16:276-81.
31. Hunter CP, Tannenbaum H, Churchill WH, Moloney WC, Schur PH. Immunologic abnormalities in patients with malignant lymphoproliferative diseases. J Natl Cancer Inst. 1977;58:1185-90. (Pubitemid 8096277)
32. Gergely L, Vancsa A, Miltenyi Z, Simon Z, Barath S, Illes A. Pretreatment T lymphocyte numbers are contributing to the prognostic significance of absolute lymphocyte numbers in B-cell non-Hodgkins lymphomas. Pathol Oncol Res. 2011;17:249-55.